Unfortunately, the abundance of side-effects in these traditional TNF inhibitors (including immunological dysfunction and even the induction of pancreatitis itself [10–13]), combined with their apparent inability to reduce mortality in sepsis patients [14, 15] dampened enthusiasm for their further use in patients with pancreatitis. Here, TNF is linked to pancreatitis.